NMG

品系全名

NOD.Cg-PrkdcscidIl2rgem1Smoc

目录号

NM-NSG-001

品系状态

活体

导出PDF

基因信息

基因名
IL2RG

品系描述

Prkdc and Il2rg genes were both knocked-out in NOD mice. Lacking mature T, B and NK cells; Low immune rejection against human cells and tissues; Good tumorigenicity so that a small number of cells can form tumors; Significant improvement in the survival of transplanted human cells and tissues; Suitable for the transplantation of human hematopoietic stem cells and the preparation of humanized mouse models; Suitable as the carrier mice for the transplantation of heterologous cells and tissues.
应用领域:Immune and hematopoietic research

验证数据

image.png

Figure 1. Complete deletion of T, B and NK cells in the spleen of NMG mice.(A) The splenocytes of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of T, B and NK cells by FACS. (B) Statistical analysis of sorted cells.

图层 10.png

Figure 2. Complete deletion of T, B and NK cells in the blood of NMG mice.(A) The peripheral blood samples of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of T, B and NK cells by FACS.(B) Statistical analysis of sorted cells.


图层 9.png

Figure 3. Compositions of monocytes, macrophages, DCs in the spleen of NMG mice. (A) The splenocytes of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of monocytes, macrophages, DCs. (B) Statistical analysis of sorted cells.


图层 17.png

Figure 4. Compositions of monocytes, macrophages, DCs in the blood of NMG mice. (A) The peripheral blood samples of BALB/c, NOD-scid and NMG mice were collected to analyze their compositions of monocytes, macrophages, DCs. (B) Statistical analysis of sorted cells.


image.png

Figure 5. Histological sections of various tissues from NMG mice. Furthermore, no significant abnormalities were observed in other tissues, including brain, retina, spinal cord, heart, liver, lung, kidney, small intestine, large intestine, stomach, salivary glands, pancreas, ovary, uterus, testis, epididymis, skeletal muscle, skin, and brown fat. 


image.png

Fig6.Serum antibody response in the serum of BALB/c, NOD-SCID, NMG and Blank. (n=5, 8-week-old, male)


图层 18.png

Fig7. The establishment of tumor models using A549 or Raji cells is more effective in NMG mice.


A CDX model has been successfully established in NMG mice

图片3.png


image.png

Fig8. In vivo Efficacy Study of Anti-human CD47 Reference Antibody in the Treatment of Raji lymphoma CDX Tumor model in NMG mice.


image.png

Fig9. CAR-T in vivo efficacy study of A549 NSCLC model in NMG mice


image.png

Fig10. PBMC reconstitution model. Human PBMC cells were intravenous implanted into homozygote NMG mice. Percentage of human CD45+ cells (A),  body weight (B).


image.png

Fig11.  In vivo Efficacy Study of Hu-PBMC Reconstruction Model in NMG mice.


image.png

Fig12. Analysis of peripheral blood lymphocyte subpopulations of NMG mice after implantation of human CD34+ HSC at different times.


image.png

Fig13. Drug efficacy evaluation study performed in NMG mice reconstituted with hCD34+ cells. Humanized NMG mice reconstituted with human CD34+ cells were i.v. injected with MDA-MB-231 cells.

image.png

Fig14. Body weight growth curve of NMG.



发表文献 59篇

1. Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells
发表年份:2024 来源杂志:NATURE MATERIALS

2. An oncolytic virus–T cell chimera for cancer immunotherapy
发表年份:2024 来源杂志:NATURE BIOTECHNOLOGY

3. The N6-methyladenosine Epitranscriptomic Landscape of Lung Adenocarcinoma
发表年份:2024 来源杂志:Cancer Discovery

4. Dietary elaidic acid boosts tumoral antigen presentation and cancer immunity via ACSL5
发表年份:2024 来源杂志:Cell Metabolism

5. Mitochondrial isocitrate dehydrogenase impedes CAR T cell function by restraining antioxidant metabolism and histone acetylation
发表年份:2024 来源杂志:Cell Metabolism

6. A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway
发表年份:2024 来源杂志:Molecular Cancer

7. Photo-metallo-immunotherapy: Fabricating Chromium-Based Nanocomposites to Enhance CAR-T Cell Infiltration and Cytotoxicity against Solid Tumors
发表年份:2024 来源杂志:ADVANCED MATERIALS

8. Acetylation-dependent regulation of core spliceosome modulates hepatocellular carcinoma cassette exons and sensitivity to PARP inhibitors
发表年份:2024 来源杂志:Nature Communications

9. FLI1 promotes IFN-γ-induced kynurenine production to impair anti-tumor immunity
发表年份:2024 来源杂志:Nature Communications

10. PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma
发表年份:2024 来源杂志:Nature Communications

11. Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy
发表年份:2024 来源杂志:Nature Communications

12. Protein Kinase STK24 Promotes Tumor Immune Evasion via the AKT-PD-L1 Axis
发表年份:2024 来源杂志:Advanced Science

13. Kidney Organoid Modeling of WT1 Mutations Reveals Key Regulatory Paths Underlying Podocyte Development
发表年份:2024 来源杂志:Advanced Science

14. A pan-KRAS degrader for the treatment of KRAS-mutant cancers
发表年份:2024 来源杂志:Cell Discovery

15. Foretinib is effective in acute myeloid leukemia by inhibiting FLT3 and overcoming secondary mutations that drive resistance to quizartinib and gilteritinib
发表年份:2024 来源杂志:CANCER RESEARCH

16. HDAC6-dependent deacetylation of NGF dictates its ubiquitination and maintains primordial follicle dormancy
发表年份:2024 来源杂志:Theranostics

17. Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease
发表年份:2024 来源杂志:Gut Microbes

18. Venetoclax acts as an immunometabolic modulator to potentiate adoptive NK cell immunotherapy against leukemia
发表年份:2024 来源杂志:Cell Reports Medicine

19. iPSC-derived NK cells with site-specific integration of CAR19 and IL24 at the multi-copy rDNA locus enhanced antitumor activity and proliferation
发表年份:2024 来源杂志:MedComm

20. Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy
发表年份:2024 来源杂志:JOURNAL OF NANOBIOTECHNOLOGY

21. RCAd-LTH-shPD-L1, a double-gene recombinant oncolytic adenovirus with enhanced antitumor immunity, increases lymphocyte infiltration and reshapes the tumor microenvironment
发表年份:2024 来源杂志:Journal for ImmunoTherapy of Cancer

22. TYM-3-98, a novel selective inhibitor of PI3Kδ, demonstrates promising preclinical antitumor activity in B-cell lymphomas
发表年份:2024 来源杂志:LIFE SCIENCES

23. The CDK4/6 inhibitor Palbociclib synergizes with ATRA to induce differentiation in AML
发表年份:2024 来源杂志:MOLECULAR CANCER THERAPEUTICS

24. INPP4B suppresses HER2-induced mesenchymal transition in HER2+ breast cancer and enhances sensitivity to Lapatinib
发表年份:2024 来源杂志:BIOCHEMICAL PHARMACOLOGY

25. PHE1-based IgG-like antibody platform provides a novel strategy for enhanced T-cell immunotherapy
发表年份:2024 来源杂志:Frontiers in Immunology

26. Lactate/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer
发表年份:2024 来源杂志:OncoImmunology

27. Dehydrocostus lactone alleviates irinotecan-induced intestinal mucositis by blocking TLR4/MD2 complex formation
发表年份:2024 来源杂志:PHYTOMEDICINE

28. Restoring T and B cell generation in X-linked severe combined immunodeficiency mice through hematopoietic stem cells adenine base editing
发表年份:2024 来源杂志:MOLECULAR THERAPY

29. Small-molecule α-lipoic acid targets ELK1 to balance human neutrophil and erythrocyte differentiation
发表年份:2024 来源杂志:Stem Cell Research & Therapy

30. FAM120A deficiency improves resistance to cisplatin in gastric cancer by promoting ferroptosis
发表年份:2024 来源杂志:Communications Biology

31. IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer
发表年份:2024 来源杂志:INTERNATIONAL IMMUNOPHARMACOLOGY

32. ARID5A stabilizes Indoleamine 2,3-dioxygenase expression and enhances CAR T cell exhaustion in colorectal cancer
发表年份:2024 来源杂志:Translational Oncology

33. HDAC inhibitors target IRS4 to enhance anti‑AR therapy in AR‑positive triple‑negative breast cancer
发表年份:2024 来源杂志:INTERNATIONAL JOURNAL OF ONCOLOGY

34. Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer model
发表年份:2024 来源杂志:EJNMMI Radiopharmacy and Chemistry

35. Effective in vivo reactivation of HIV-1 latency reservoir via oral administration of EK-16A-SNEDDS
发表年份:2024 来源杂志:EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

36. PLA2G2D promotes immune escape in non-small cell lung cancer by regulating T cell immune function through PD-L1-expressing extracellular vesicles
发表年份:2024 来源杂志:SCANDINAVIAN JOURNAL OF IMMUNOLOGY

37. Discovery of Phenylpyrazole Derivatives as a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity
发表年份:2024 来源杂志:ACS Omega

38. FYB1-targeted modulation of CAPG promotes AML progression
发表年份:2024 来源杂志:MOLECULAR AND CELLULAR BIOCHEMISTRY

39. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome
发表年份:2024 来源杂志:DNA AND CELL BIOLOGY

40. Regional delivery of mesothelin-targeted chimeric antigen receptor T-cell effectively and safely targets colorectal cancer liver metastases in mice
发表年份:2024 来源杂志:Journal of Gastrointestinal Oncology

41. Small extracellular vesicle piR-hsa-30937 derived from pancreatic neuroendocrine neoplasms upregulates CD276 in macrophages to promote immune evasion
发表年份:2024 来源杂志:Cancer Immunology Research

42. Histidine re-sensitizes pediatric acute lymphoblastic leukemia to 6-mercaptopurine through tetrahydrofolate consumption and SIRT5-mediated desuccinylation
发表年份:2024 来源杂志:Cell Death & Disease

43. LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
发表年份:2024 来源杂志:Cell Death & Disease

44. Cisplatin-induced Pyroptosis Enhances the Efficacy of PD-L1 Inhibitor in Small-Cell Lung Cancer via GSDME/IL12/CD4Tem Axis
发表年份:2024 来源杂志:International Journal of Biological Sciences

45. miR-590-3p Overexpression Improves the Efficacy of hiPSC-CMs for Myocardial Repair
发表年份:2024 来源杂志:JACC-Basic to Translational Science

46. Mid1 promotes synovitis in rheumatoid arthritis via ubiquitin-dependent post-translational modification
发表年份:2024 来源杂志:PHARMACOLOGICAL RESEARCH

47. Targeting high circDNA2v levels in colorectal cancer induces cellular senescence and elicits an anti-tumor secretome
发表年份:2024 来源杂志:Cell Reports

48. Exosome-derived circCCAR1 promotes CD8+T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份:2023-03-18 来源杂志:Molecular Cancer

49. Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma
发表年份:2023-03-12 来源杂志:International Journal of Molecular Sciences

50. T cell receptor β-chain-targeting chimeric antigen receptor T cells against T cell malignancies
发表年份:2022-07-26 来源杂志:nature communications

51. A Chimeric Conjugate of Antibody and Programmable DNA Nanoassembly Smartly Activates T cell for Precise Cancer Cell Targeting
发表年份:2022-06-24 来源杂志:A Journal of the Gesellschaft Deutscher Chemiker

52. Therapeutic strategies targeting uPAR potentiate anti–PD-1 efficacy in diffuse-type gastric cancer
发表年份:2022 来源杂志:Science Advances

53. An armed oncolytic virus enhances the efficacy of tumor-infiltrating lymphocyte therapy by converting tumors to artificial antigen-presenting cells in situ
发表年份:2022 来源杂志:MOLECULAR THERAPY

54. Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
发表年份:2021-03-11 来源杂志:Front. Immunol

55. Bcl-2 Enhances Chimeric Antigen Receptor T Cell Persistence by Reducing Activation-Induced Apoptosis
发表年份:2021-01-08 来源杂志:Cancers

56. A chimeric antigen receptor with antigen-independent OX40 signaling mediates potent antitumor activity
发表年份:2021 来源杂志:Science Translational Medicine

57. 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells
发表年份:2020-11-13 来源杂志:Frontiers in Immunology

58. SH3RF3 promotes breast cancer stem-like properties via JNK activation and PTX3 upregulation
发表年份:2020-05-19 来源杂志:NAT COMMUN

59. Peptide Self-Assembly Nanoparticles Loaded with Panobinostat to Activate Latent Human Immunodeficiency Virus
发表年份:2019-05-01 来源杂志:J Biomed Nanotechnol

展开

你也可能感兴趣

Tamoxifen诱导Cre-ERT2小鼠 使用指南

Cre-ERT2在无Tamoxifen诱导的情况下,在细胞质内处于无活性状态;当Tamoxifen诱导后,Tamoxifen的代谢产物4-OHT(雌激素类似物)与ERT结合,可使Cre-ERT2进核发挥Cre重组酶活性。

查看
【小鼠大学问】基因工程小鼠的命名规则

常见的基因工程小鼠可以分为两种命名方式,包括基因定点修饰的小鼠命名,比如:敲除、敲入、点突变等等,和随机转基因的小鼠命名。

查看